• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用 CRISPR/Cas9 系统在 ATP7B 基因中进行同源定向精确点突变生产威尔逊病模型兔。

Production of Wilson Disease Model Rabbits with Homology-Directed Precision Point Mutations in the ATP7B Gene Using the CRISPR/Cas9 System.

机构信息

Department of Laboratory Animal Science, School of Medicine, Shanghai Jiao Tong University, 200025, Shanghai, China.

School of Life Science and Technology, Shanghai Tech University, 201210, Shanghai, China.

出版信息

Sci Rep. 2018 Jan 22;8(1):1332. doi: 10.1038/s41598-018-19774-4.

DOI:10.1038/s41598-018-19774-4
PMID:29358698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5778067/
Abstract

CRISPR/Cas9 has recently been developed as an efficient genome engineering tool. The rabbit is a suitable animal model for studies of metabolic diseases. In this study, we generated ATP7B site-directed point mutation rabbits to simulate a major mutation type in Asians (p. Arg778Leu) with Wilson disease (WD) by using the CRISPR/Cas9 system combined with single-strand DNA oligonucleotides (ssODNs). The efficiency of the precision point mutation was 52.94% when zygotes were injected 14 hours after HCG treatment and was significantly higher than that of zygotes injected 19 hours after HCG treatment (14.29%). The rabbits carrying the allele with mutant ATP7B died at approximately three months of age. Additionally, the copper content in the livers of rabbits at the onset of WD increased nine-fold, a level similar to the five-fold increase observed in humans with WD. Thus, the efficiency of precision point mutations increases when RNAs are injected into zygotes at earlier stages, and the ATP7B mutant rabbits are a potential model for human WD disease with applications in pathological analysis, clinical treatment and gene therapy research.

摘要

CRISPR/Cas9 最近被开发为一种高效的基因组工程工具。兔子是代谢性疾病研究的合适动物模型。在这项研究中,我们通过使用 CRISPR/Cas9 系统结合单链 DNA 寡核苷酸(ssODNs),生成了 ATP7B 定点突变兔,以模拟威尔逊病(WD)中亚洲人主要的突变类型(p.Arg778Leu)。当受精卵在 hCG 处理后 14 小时注射时,精确点突变的效率为 52.94%,明显高于 hCG 处理后 19 小时注射的受精卵(14.29%)。携带突变 ATP7B 等位基因的兔子在大约三个月大时死亡。此外,WD 发病时兔子肝脏中的铜含量增加了九倍,与 WD 患者观察到的五倍增加相似。因此,当 RNA 更早地注入受精卵时,精确点突变的效率会增加,而 ATP7B 突变兔是一种潜在的人类 WD 疾病模型,可应用于病理分析、临床治疗和基因治疗研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a24/5778067/2fc8052cbcfd/41598_2018_19774_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a24/5778067/ffd57f9b5d1e/41598_2018_19774_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a24/5778067/69880acdddc4/41598_2018_19774_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a24/5778067/6e7e58ffc22c/41598_2018_19774_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a24/5778067/e633f8767f2f/41598_2018_19774_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a24/5778067/739652de65e7/41598_2018_19774_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a24/5778067/e356eb8e93a8/41598_2018_19774_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a24/5778067/8b0c54af0982/41598_2018_19774_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a24/5778067/504310cb2e50/41598_2018_19774_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a24/5778067/2fc8052cbcfd/41598_2018_19774_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a24/5778067/ffd57f9b5d1e/41598_2018_19774_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a24/5778067/69880acdddc4/41598_2018_19774_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a24/5778067/6e7e58ffc22c/41598_2018_19774_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a24/5778067/e633f8767f2f/41598_2018_19774_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a24/5778067/739652de65e7/41598_2018_19774_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a24/5778067/e356eb8e93a8/41598_2018_19774_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a24/5778067/8b0c54af0982/41598_2018_19774_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a24/5778067/504310cb2e50/41598_2018_19774_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a24/5778067/2fc8052cbcfd/41598_2018_19774_Fig9_HTML.jpg

相似文献

1
Production of Wilson Disease Model Rabbits with Homology-Directed Precision Point Mutations in the ATP7B Gene Using the CRISPR/Cas9 System.利用 CRISPR/Cas9 系统在 ATP7B 基因中进行同源定向精确点突变生产威尔逊病模型兔。
Sci Rep. 2018 Jan 22;8(1):1332. doi: 10.1038/s41598-018-19774-4.
2
CRISPR/Cas9-mediated correction of mutated copper transporter ATP7B.CRISPR/Cas9 介导的突变铜转运体 ATP7B 的校正。
PLoS One. 2020 Sep 30;15(9):e0239411. doi: 10.1371/journal.pone.0239411. eCollection 2020.
3
A Gene Therapy Approach to Improve Copper Metabolism and Prevent Liver Damage in a Mouse Model of Wilson Disease.一种基因治疗方法,用于改善威尔逊病小鼠模型中的铜代谢并预防肝损伤。
Hum Gene Ther Clin Dev. 2019 Mar;30(1):29-39. doi: 10.1089/humc.2018.219. Epub 2019 Feb 25.
4
[Research progress in gene therapy for Wilson's disease].[肝豆状核变性基因治疗的研究进展]
Zhonghua Gan Zang Bing Za Zhi. 2021 Jan 20;29(1):21-24. doi: 10.3760/cma.j.cn501113-20201104-00598.
5
Spectrum of ATP7B mutations and genotype-phenotype correlation in large-scale Chinese patients with Wilson Disease.中国大规模肝豆状核变性患者ATP7B基因突变谱及基因型-表型相关性研究
Clin Genet. 2017 Jul;92(1):69-79. doi: 10.1111/cge.12951. Epub 2017 Feb 16.
6
Animal models of Wilson disease.威尔逊病的动物模型。
Handb Clin Neurol. 2017;142:57-70. doi: 10.1016/B978-0-444-63625-6.00006-9.
7
Liver Expression of a MiniATP7B Gene Results in Long-Term Restoration of Copper Homeostasis in a Wilson Disease Model in Mice.肝脏表达微型 ATP7B 基因可长期恢复威尔逊病模型小鼠的铜稳态。
Hepatology. 2019 Jul;70(1):108-126. doi: 10.1002/hep.30535. Epub 2019 Mar 20.
8
Animal models of Wilson disease.威尔逊病的动物模型。
J Neurochem. 2018 Aug;146(4):356-373. doi: 10.1111/jnc.14323. Epub 2018 Jun 26.
9
Disease-causing point-mutations in metal-binding domains of Wilson disease protein decrease stability and increase structural dynamics.威尔逊病蛋白金属结合域中的致病点突变会降低稳定性并增加结构动力学。
Biometals. 2017 Feb;30(1):27-35. doi: 10.1007/s10534-016-9976-7. Epub 2016 Oct 15.
10
Insertional Mutagenesis by CRISPR/Cas9 Ribonucleoprotein Gene Editing in Cells Targeted for Point Mutation Repair Directed by Short Single-Stranded DNA Oligonucleotides.通过CRISPR/Cas9核糖核蛋白基因编辑在由短单链DNA寡核苷酸引导的点突变修复靶向细胞中进行插入诱变。
PLoS One. 2017 Jan 4;12(1):e0169350. doi: 10.1371/journal.pone.0169350. eCollection 2017.

引用本文的文献

1
Emerging and potential use of CRISPR in human liver disease.CRISPR在人类肝脏疾病中的新兴及潜在应用。
Hepatology. 2023 Aug 22. doi: 10.1097/HEP.0000000000000578.
2
Genetically Modified Rabbits for Cardiovascular Research.用于心血管研究的转基因兔子
Front Genet. 2021 Feb 2;12:614379. doi: 10.3389/fgene.2021.614379. eCollection 2021.
3
One-step generation of a targeted knock-in calf using the CRISPR-Cas9 system in bovine zygotes.利用CRISPR-Cas9系统在牛受精卵中一步生成靶向敲入小牛。

本文引用的文献

1
Mechanisms of precise genome editing using oligonucleotide donors.使用寡核苷酸供体进行精确基因组编辑的机制。
Genome Res. 2017 Jul;27(7):1099-1111. doi: 10.1101/gr.214775.116. Epub 2017 Mar 29.
2
CRISPR/Cas9-mediated mutation of PHEX in rabbit recapitulates human X-linked hypophosphatemia (XLH).CRISPR/Cas9介导的兔PHEX基因突变模拟了人类X连锁低磷血症(XLH)。
Hum Mol Genet. 2016 Jul 1;25(13):2661-2671. doi: 10.1093/hmg/ddw125. Epub 2016 Apr 28.
3
Identification and characterization of rabbit ROSA26 for gene knock-in and stable reporter gene expression.
BMC Genomics. 2021 Feb 12;22(1):118. doi: 10.1186/s12864-021-07418-3.
4
The future of gene-targeted therapy for hereditary tyrosinemia type 1 as a lead indication among the inborn errors of metabolism.作为先天性代谢缺陷中的主要适应症,1型遗传性酪氨酸血症基因靶向治疗的未来。
Expert Opin Orphan Drugs. 2020;8(7):245-256. doi: 10.1080/21678707.2020.1791082. Epub 2020 Jul 21.
5
CRISPR/Cas9-mediated correction of mutated copper transporter ATP7B.CRISPR/Cas9 介导的突变铜转运体 ATP7B 的校正。
PLoS One. 2020 Sep 30;15(9):e0239411. doi: 10.1371/journal.pone.0239411. eCollection 2020.
6
Genome engineering technologies in rabbits.兔基因组工程技术
J Biomed Res. 2020 Jun 12;35(2):135-147. doi: 10.7555/JBR.34.20190133.
7
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects.基因组编辑技术在人类疾病靶向治疗中的应用:机制、进展与展望。
Signal Transduct Target Ther. 2020 Jan 3;5(1):1. doi: 10.1038/s41392-019-0089-y.
8
ATP7B knockout disturbs copper and lipid metabolism in Caco-2 cells.ATP7B 基因敲除扰乱 Caco-2 细胞中的铜和脂质代谢。
PLoS One. 2020 Mar 10;15(3):e0230025. doi: 10.1371/journal.pone.0230025. eCollection 2020.
9
Using CRISPR/Cas9 to model human liver disease.利用CRISPR/Cas9对人类肝脏疾病进行建模。
JHEP Rep. 2019 Oct 25;1(5):392-402. doi: 10.1016/j.jhepr.2019.09.002. eCollection 2019 Nov.
10
Applications of Genome Editing Technology in Animal Disease Modeling and Gene Therapy.基因组编辑技术在动物疾病模型构建和基因治疗中的应用。
Comput Struct Biotechnol J. 2019 Jun 8;17:689-698. doi: 10.1016/j.csbj.2019.05.006. eCollection 2019.
用于基因敲入和稳定报告基因表达的兔ROSA26的鉴定与表征。
Sci Rep. 2016 Apr 27;6:25161. doi: 10.1038/srep25161.
4
Efficient Generation of Myostatin Gene Mutated Rabbit by CRISPR/Cas9.利用CRISPR/Cas9高效生成肌肉生长抑制素基因变异兔
Sci Rep. 2016 Apr 26;6:25029. doi: 10.1038/srep25029.
5
Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo.通过在体内联合病毒和非病毒递送CRISPR系统组件进行治疗性基因组编辑。
Nat Biotechnol. 2016 Mar;34(3):328-33. doi: 10.1038/nbt.3471. Epub 2016 Feb 1.
6
A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice.一种双腺相关病毒(AAV)系统能够在新生小鼠中实现Cas9介导的代谢性肝病矫正。
Nat Biotechnol. 2016 Mar;34(3):334-8. doi: 10.1038/nbt.3469. Epub 2016 Feb 1.
7
Efficient dual sgRNA-directed large gene deletion in rabbit with CRISPR/Cas9 system.利用CRISPR/Cas9系统在兔中高效进行双sgRNA引导的大基因缺失
Cell Mol Life Sci. 2016 Aug;73(15):2959-68. doi: 10.1007/s00018-016-2143-z. Epub 2016 Jan 27.
8
Generation of hypoxanthine phosphoribosyltransferase gene knockout rabbits by homologous recombination and gene trapping through somatic cell nuclear transfer.通过同源重组和体细胞克隆核移植中的基因捕获技术构建次黄嘌呤磷酸核糖基转移酶基因敲除兔。
Sci Rep. 2015 Nov 2;5:16023. doi: 10.1038/srep16023.
9
Specific and global coagulation tests in patients with mild haemophilia A with a double mutation (Glu113Asp, Arg593Cys).轻度甲型血友病双突变(Glu113Asp、Arg593Cys)患者的特异性及全面凝血试验
Blood Transfus. 2015 Oct;13(4):622-30. doi: 10.2450/2015.0321-14. Epub 2015 May 15.
10
A SNP in the HTT promoter alters NF-κB binding and is a bidirectional genetic modifier of Huntington disease.HTT 启动子中的 SNP 改变了 NF-κB 的结合,是亨廷顿病的双向遗传修饰子。
Nat Neurosci. 2015 Jun;18(6):807-16. doi: 10.1038/nn.4014. Epub 2015 May 4.